• OPEN AN ACCOUNT
Indian Indices
Sensex
78,094.64 166.49
( 0.21%)
Global Indices
Nasdaq
52,497.89 268.83
(0.51%)
Dow Jones
7,510.69 52.06
(0.70%)
Hang Seng
64,316.33 2,448.90
(3.96%)
Nikkei 225
10,879.26 -18.01
(-0.17%)
Forex
USD-INR
95.59 -0.10
(-0.11%)
EUR-INR
109.79 0.65
(0.59%)
GBP-INR
128.11 0.75
(0.59%)
JPY-INR
0.59 0.01
(1.09%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
132.2958859
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
49.51
44951.04
EPS(TTM)
Face Value()
Div & Yield %
53.59
10
2.15
 

Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
May 13,2026
Net profit of Glaxosmithkline Pharmaceuticals rose 5.70% to Rs 277.86 crore in the quarter ended March 2026 as against Rs 262.87 crore during the previous quarter ended March 2025. Sales rose 2.15% to Rs 995.30 crore in the quarter ended March 2026 as against Rs 974.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.69% to Rs 1035.98 crore in the year ended March 2026 as against Rs 927.58 crore during the previous year ended March 2025. Sales rose 1.93% to Rs 3821.67 crore in the year ended March 2026 as against Rs 3749.21 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales995.30974.37 2 3821.673749.21 2
OPM %35.2634.20 -34.2631.40 -
PBDT386.27373.29 3 1451.831321.98 10
PBT373.10358.57 4 1385.391255.19 10
NP277.86262.87 6 1035.98927.58 12